GSA Capital Partners’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,835
| Closed | -$304K | – | 1698 |
|
|
2025
Q1 | $304K | Sell |
63,835
-42,690
| -40% | -$203K | 0.03% | 1141 |
|
|
2024
Q4 | $593K | Buy |
106,525
+10,433
| +11% | +$58.1K | 0.04% | 758 |
|
|
2024
Q3 | $607K | Buy |
96,092
+33,831
| +54% | +$214K | 0.05% | 795 |
|
|
2024
Q2 | $264K | Buy |
62,261
+37,700
| +153% | +$160K | 0.02% | 1335 |
|
|
2024
Q1 | $178K | Buy |
+24,561
| New | +$178K | 0.01% | 1426 |
|
|
2023
Q4 | – | Sell |
-11,638
| Closed | -$49K | – | 1439 |
|
|
2023
Q3 | $49K | Buy |
+11,638
| New | +$49K | ﹤0.01% | 1419 |
|
|
2022
Q1 | – | Sell |
-31,523
| Closed | -$266K | – | 1359 |
|
|
2021
Q4 | $266K | Buy |
31,523
+30,184
| +2,254% | +$255K | 0.03% | 1024 |
|
|
2021
Q3 | $37K | Buy |
+1,339
| New | +$37K | ﹤0.01% | 1355 |
|
|
2020
Q4 | – | Sell |
-444
| Closed | -$11K | – | 1154 |
|
|
2020
Q3 | $11K | Buy |
+444
| New | +$11K | ﹤0.01% | 1222 |
|
|
2019
Q3 | – | Sell |
-805
| Closed | -$96K | – | 1350 |
|
|
2019
Q2 | $96K | Buy |
+805
| New | +$96K | 0.01% | 1345 |
|